SAN DIEGO, June 10, 2015 /PRNewswire/ -- New results
from S+ by ResMed, the world's first non-contact sleep system, show
that after only one week of use, more than two-thirds of users with
below-average sleep scores saw significant improvement. ResMed
(NYSE: RMD), the global leader in the treatment of sleep-disordered
breathing and other respiratory conditions, announced that 67% of
such S+ users saw improved sleep times after the first week of use
– an average of 31 minutes of extra sleep per night – once they
began using the device.
Released in October 2014, the S+
by ResMed is a personalized sleep solution using patented
bio-motion sensors to monitor and analyze sleep. The device
measures an individual's sleep stages and sleeping environment to
deliver daily sleep scores and provide personalized feedback to
help improve sleep. It uses ResMed's proprietary touchless
monitoring technology, allowing users to simply turn on the device
at bedtime and eliminate the need to wear a watch, wristband, or
other sensor.
"More than 50% of Americans have trouble sleeping and many of
them don't understand why," said Colin
Lawlor, vice president, ResMed consumer business. "These
results show that gaining a better understanding of sleep patterns
is an important first step toward improving the quality of your
sleep. The S+ provides that insight, whether it suggests that you
take an evening walk or notices that early morning light may be
impacting your sleep."
S+ monitors sleeping patterns from the users' bedside table,
sending real-time sleep information to the S+ by ResMed app,
available on iOS- or Android-enabled devices. The data is then laid
out on easy-to-read charts and graphs that help set users on a path
toward better sleep. The app also includes several additional
features that help users fall to sleep with greater ease.
ResMed has more than 25 years of experience in the sleep
industry. S+ provides personalized feedback, finely tuned from
extensive research and studies informed by more than two million
hours of actual sleep data. Users can also download a personalized
sleep report that can be shared with a physician to facilitate a
discussion on their sleep trends.
For more information about the results of the study, derived
from a sample of all S+ users as of 03/19/2015, or to learn more
about the S+ by ResMed, visit http://mysplus.com. S+ is available
online and at retail stores including Apple, Bed Bath & Beyond
and Best Buy. Consumers can purchase the device for $99.99 for a limited time from select
retailers.
ResMed is committed to protecting the privacy and security of
personally identifiable information. Sleep data collected for this
report was analyzed in the aggregate. For more information on
ResMed's S+ privacy policy, visit
https://sleep.mysplus.com/privacy-policy.html.
About ResMed
The global team at ResMed (NYSE:RMD) is
united in its commitment to changing lives with every
breath. With more than 4,000 employees and a presence in over
100 countries, the company has been pioneering new and innovative
devices and treatments for sleep-disordered breathing, chronic
obstructive pulmonary disease, and other key chronic diseases for
more than 25 years. ResMed's world-leading products and innovative
solutions improve the quality of life for millions of patients
worldwide, reduce the impact of chronic disease, and save
healthcare costs. For more information about ResMed and its
businesses, visit www.resmed.com or follow @resmed on
Twitter.
Contacts:
|
|
For News
Media
|
For
Investors
|
Alison
Graves
|
Agnes Lee
|
Director, Corporate
Communications
|
Senior Director,
Investor Relations
|
O:
858-836-6789
|
O:
858-836-5971
|
news@resmed.com
|
investorrelations@resmed.com
|
Logo -
http://photos.prnewswire.com/prnh/20140310/LA79234LOGO-a
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/the-results-are-in-s-by-resmed-users-see-improvement-in-the-amount-and-quality-of-their-sleep-300097278.html
SOURCE ResMed Inc.